Hepatitis B Virus Core Antigen (HBcAg) anticorps

N° du produit ABIN722991

Cet anticorps anti- est un anticorps Souris Monoclonal détectant dans ELISA, IHC (p) et IF (p). Adapté pour Hepatitis B Virus (HBV) et Virus.

Aperçu rapide pour Hepatitis B Virus Core Antigen (HBcAg) anticorps (ABIN722991)

Antigène: Hepatitis B Virus Core Antigen (HBcAg)

Reactivité: Hepatitis B Virus (HBV), Virus

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Inconjugué

Application: ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Clone: 1H8

Détail du produit

Réactivité croisée: Virus

Réactivité croisée (Details): Hepatitis B Virus

Purification: Purified by Protein G.

Immunogène: Recombinant Hepatitis B Core Antigen (rHBcAg)

Isotype: IgG

Information d'application

Indications d'application: ELISA 1:500-1000
IHC-P 1:200-400
IF(IHC-P) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C for 12 months.

Date de péremption: 12 months

Détail du antigène

Antigène: Hepatitis B Virus Core Antigen (HBcAg)

Autre désignation: HBcAg

Classe de substances: Viral Protein

Sujet:

Synonyms: C, Capsid protein, Core and e antigen, Core antigen, Core antigen, Core protein, HBc, HBcAg, HBVgp4, Hepatitis B Virus core antigen, p21.5, precore/core protein, CAPSD_HBVA3.

Background: Hepatitis B Virus Core Antigen (HBcAg) is part of the infectious virion containing an inner "core particle" enclosing the viral genome. The icosahedral core particle contains 180 or 240 copies of the core protein. HBcAg is one of the three major clinical antigens of hepatitis B virus but disappears early in the course of infection.The hepatitis B virus core antigen (HBcAg) is a highly immunogenic subviral particle and functions as both a T-cell-dependent and a T-cell-independent antigen. Therefore, HBcAg may be a promising candidate target for therapeutic vaccine control of chronic HBV infection.